BUY PSILOCYBE WEILII ONLINE IN US\UK
Psilocybe Weilii is a naturally occurring psychedelic substance produce by psilocybin mushrooms, also called ‘magic’ mushrooms. With the modern revival of psychedelic research, psilocybin is being investigated for its potential to help people overcome depression and anxiety. Read on to learn about the history of its use and the intriguing current research.
In clinical studies, the effective oral dose was 10-30 mg/70kg or 0.045-0.429 mg/kg, and 1-2 mg per adult intravenously. The minimal dose for psychedelic effects was 15 mg orally. And when it comes to the current research, safety guidelines state that high oral doses of psilocybin are >25 mg
If taken orally, psilocybin converts to psilocin, its active form, in the liver. Psilocin then enters the bloodstream and reaches the brain.
Other adverse effects that occurred in clinical studies include.
- A slight increase in blood pressure or heart rate
- Unusual body sensations
- Mood changes
- Fatigue and yawning
Psilocybin (chemically known as 4-phosphoryl oxy-N, N-dimethyltryptamine) is a classic psychedelic that belongs to the group of hallucinogenic tryptamines. But the story about psilocybin indigenous use and modern research over the past century is anything but classic.
Despite the recent renaissance in psychedelic research, there is a lot of controversy surrounding psilocybin use, its legal status, and its potential therapeutic effects. Not many people know the whole story behind the traditional use of psilocybin-containing mushrooms, nor about the efforts that produced our current state of knowledge about it.
Psilocybe Weilii Strain
Psilocybe has a glutinous taste and a doughy scent. At times, it may be similar to cucumber. To identify this magic mushroom, it’s important to look at its four different features: cap, gills, spores, and stipe.
This magic mushroom has an obtusely conic cap measuring from 3cm to 6cm across. Sometimes, this may also be shaped like a bell. It has a translucent stripe and is usually colored purple-brown or chestnut brown to dark brown. As it dries, the color changes to buff or straw yellow while the nipple-like center remains blackish brown.
Even the cap margin of this shroom has defining features. It starts off with an incurved edge but becomes forms irregular lobes as it grows older. Scale-like remnants are often seen along the margin. The cap’s flesh is also white, bruising a strong blue, and sometimes completely blue-black.
The gills are closely, and regularly aligned beneath the cap. They are cream to light brown or brownish-yellow. As the mushroom and its spores mature, the gills turn purple and brown. Gill edges are usually hairy, with small tufts of white.
Psilocybe weilii’s stem ranges from 4cm to 7cm in length and approximately 5mm to 1cm in thickness. It has an equal structure but it can be seen bulging at some parts, especially towards the base where it is obviously thicker for support.
Psilocybe Weilii Habitat and Distribution
It loves growing under Loblolly Pine and Sweetgum or in Bermuda grass. It also prefers red clay soil as long as the ground is enriched with pine needles. It’s also a wood-loving variety as evidenced by its preference for urban lawns and deep woods where decaying woods and debris collect.
In one instance fourteen years ago, in the town of Suwanee, a ¼ mile clearing had thousands of fruiting Psilocybe while. Some of them were gigantic, even reaching 5 inches in diameter. After the Suwanee town councilors found the leak in the sewage pipes underneath it, the mushrooms never sprouted in that specific location again. This magic mushroom flourishes from May to December.
Psilocybe Weilii and Legal Mushroom Therapy
The Psilocybin Society based in Oregon, USA has taken steps to push for the legalization and regulation of psilocybin-assisted therapy. A growing number of supporters are pushing for this policy’s approval and implementation because of the latest research.
These studies showed that the administration of psilocybin in a therapeutic setting will combat anxiety, depression, addiction, compulsive disorder, and cluster headaches, and even promote creative thinking. Even in higher doses, psilocybin doesn’t cause toxicity nor cause any serious threats to a healthy human mind and body. Reports of addiction are non-existent.
In depressive patients, a single dose of psilocybin will provide a psychedelic experience and improve one’s disposition for several months. It can also eliminate the need for daily psychiatric medications. Taking psilocybin in a clinical setting involves preparation, psychological support, and psilocybin administration. Where traditional medications fail, psilocybin produces impressive results.
Fortunately, attitudes surrounding magic shrooms are evolving and becoming more progressive. With every successful research, it’s reasonable to expect more positive outcomes. More positive results will eventually mean new policies at the state and federal levels. For that reason, the Psilocybin Society decided to mobilize in Oregon last spring of 2016. As of today, this society is still growing strong.